POMC and pituitary tumor: Heaney et al. demonstrated that rosiglitazone exhibited in vitro anti-proliferative and pro-apoptotic effects in human and murine ACTH-secreting pituitary tumour cells, it effectively prevented the in vivo development of corticotroph tumours and it suppressed ACTH secretion in murine models [74].